Question 1

Which is bigger, LLY or TEVA?

Accepted Answer

Eli Lilly & Co. is the larger company — market cap $1.05T vs $48.1B for Teva Pharmaceutical Industries Limited.

Question 2

Which is more profitable, LLY or TEVA?

Accepted Answer

LLY keeps more of each revenue dollar as profit — net margin 33.5% vs 4.1% for TEVA.

Question 3

Which stock is cheaper, LLY or TEVA?

Accepted Answer

On earnings, LLY trades at a lower P/E — 41.6 vs 63.2 for TEVA. A lower P/E means paying less per dollar of earnings.

Question 4

Which is the better stock — LLY or TEVA?

Accepted Answer

On reported financials, LLY leads 9 of 11 comparable metrics and TEVA leads 2. StockCV rates LLY “Solid” and TEVA “Strained”. This is information, not investment advice — compare the full CVs before drawing conclusions.

Metric	LLY	TEVA
Price	$1 177.20	$41.21
Market cap	$1.05T	$48.1B
Revenue (TTM)	$79.7B	$17.3B
Revenue growth	+31.7%	+5.0%
Net margin	33.5%	4.1%
Free cash flow	$18.2B	$1.35B
Net cash (debt)	($35.2B)	$1.74B
1-year price return	+37.6%	+105.6%
P/E	41.6	63.2
P/E vs own history (cheap-side %)	88%	0%
Dividend yield	0.52%	—
Return on equity	93%	9%
Altman Z-score	7.10	0.63
CV checks passed	11 of 11	7 of 11
Employees	50,000	32,842

Eli Lilly & Co. vs Teva Pharmaceutical Industries Limited